3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
10
Lymphoid
1
Gynecologic
1
Conditions
Pelvic Neoplasms
1
Malignant Primary Pelvic Neoplasm
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Heart Diseases
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Breast Neoplasms
1
Interventions
pembrolizumab
33
Paclitaxel
26
Cyclophosphamide
25
Carboplatin
23
olaparib
21
Fulvestrant
15
fludarabine
14
Trastuzumab
14
aldesleukin
13
Docetaxel
13
Early Intervention, Educational
12
Surveys and Questionnaires
11
veliparib
10
palbociclib
10
Methods
10
Gemcitabine
10
Blood Specimen Collection
10
Nivolumab
9
Flow Cytometry
9
Biopsy
9
Bevacizumab
9
sargramostim
8
niraparib
7
liposomal doxorubicin
7
Therapeutics
7
Taxes
7
Standard of Care
7
Psychiatric Rehabilitation
7
Magnetic Resonance Spectroscopy
7
talazoparib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Exercise Test
×
Gynecologic
×
Clear all
NCT03510689
2024-10-16
Gene-HEART
Abramson Cancer Center at Penn Medicine
Completed
79 enrolled